Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
LOTUSEYE

Lotus Eye Hospital and Institute Share Price

 

 

Lotus Eye Hospital and Institute live price: ₹110.21. It opened at ₹111 vs previous close ₹111; intraday high/low: ₹112/₹109. The 50 & 200 DMA stand at ₹110.05/₹105.87.

Lotus Eye Hospital and Institute Performance

  • Today's Low
  • ₹109
  • Today's High
  • ₹112
  • 52 Week Low
  • ₹65
  • 52 Week High
  • ₹147
  • Open Price₹111
  • Previous Close₹111
  • Volume7,523
  • 50 DMA₹110.05
  • 100 DMA₹111.13
  • 200 DMA₹105.87

Lotus Eye Hospital and Institute Chart

Investment Returns

  • Over 1 Month + 1.04%
  • Over 3 Month -0.57%
  • Over 6 Month -6.29%
  • Over 1 Year + 63.35%

Smart Investing Starts Here Start SIP with Lotus Eye Hospital and Institute for Steady Growth!

Invest Now

Lotus Eye Hospital and Institute Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 351.4
  • PEG Ratio
  • 12.8
  • Market Cap Cr
  • 229
  • P/B Ratio
  • 3.8
  • Average True Range
  • 5.21
  • EPS
  • 0.31
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.79
  • RSI
  • 53.82
  • MFI
  • 74.19

Lotus Eye Hospital and Institute Financials

Lotus Eye Hospital and Institute Technicals

EMA & SMA

Current Price
₹110.21
-1.08 (-0.97%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹107.99
  • 50 Day
  • ₹110.05
  • 100 Day
  • ₹111.13
  • 200 Day
  • ₹105.87

Resistance and Support

110.44 Pivot Speed
  • R3 114.67
  • R2 113.34
  • R1 111.77
  • S1 108.87
  • S2 107.54
  • S3 105.97

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Lotus Eye Hospital And Institute has an operating revenue of Rs. 51.62 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 3% needs improvement, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around 0% and 2% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 86 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has some strength but we want to see some buyer interest and further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Lotus Eye Hospital and Institute Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-03-17 Others To consider Voluntary Delisting of Shares. per share(5%)Final Dividend
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results
2025-05-29 Audited Results
Date Purpose Remarks
2022-09-10 FINAL Rs.0.50 per share(5%)Final Dividend
View Lotus Eye Hospital and Institute Dividend History Arrow

Lotus Eye Hospital and Institute F&O

Lotus Eye Hospital and Institute Shareholding Pattern

40.14%
0%
0%
0%
0%
36.73%
23.13%

Lotus Eye Hospital and Institute FAQs

Lotus Eye Hospital and Institute share price is ₹110 As on 22 April, 2026 | 08:05

The Market Cap of Lotus Eye Hospital and Institute is ₹229.2 Cr As on 22 April, 2026 | 08:05

The P/E ratio of Lotus Eye Hospital and Institute is 351.4 As on 22 April, 2026 | 08:05

The PB ratio of Lotus Eye Hospital and Institute is 3.8 As on 22 April, 2026 | 08:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23